20
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Lysophosphatidic acid signaling through its receptor initiates pro-fibrotic epithelial cell fibroblast communication mediated by epithelial cell derived connective tissue growth factor

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The expansion of the fibroblast pool is a critical step in organ fibrosis, but the mechanisms driving expansion remain to be fully clarified. We previously showed that lysophosphatidic acid (LPA) signaling through its receptor LPA 1 expressed on fibroblasts directly induces the recruitment of these cells. Here we tested whether LPA-LPA 1 signaling drives fibroblast proliferation and activation during the development of renal fibrosis. LPA 1-deficient (LPA 1−/−) or -sufficient (LPA 1+/+) mice were crossed to mice with green fluorescent protein expression (GFP) driven by the type I pro-collagen promoter (Col-GFP) to identify fibroblasts. Unilateral ureteral obstruction-induced increases in renal collagen were significantly, though not completely, attenuated in LPA 1−/−Col-GFP mice, as were the accumulations of both fibroblasts and myofibroblasts. Connective tissue growth factor was detected mainly in tubular epithelial cells, and its levels were suppressed in LPA 1 −/−Col-GFP mice. LPA-LPA 1 signaling directly induced connective tissue growth factor expression in primary proximal tubular epithelial cells, through a myocardin-related transcription factor-serum response factor pathway. Proximal tubular epithelial cell derived connective tissue growth factor mediated renal fibroblast proliferation and myofibroblast differentiation. Administration of an inhibitor of myocardin-related transcription factor/serum response factor suppressed obstruction-induced renal fibrosis. Thus, targeting LPA-LPA 1 signaling and/or myocardin-related transcription factor/serum response factor-induced transcription could be promising therapeutic strategies for renal fibrosis.

          Related collections

          Author and article information

          Journal
          0323470
          5428
          Kidney Int
          Kidney Int.
          Kidney international
          0085-2538
          1523-1755
          10 November 2016
          04 December 2016
          March 2017
          01 March 2018
          : 91
          : 3
          : 628-641
          Affiliations
          [1 ]Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114
          [2 ]Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114
          [3 ]Fibrosis Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114
          [4 ]Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114
          [5 ]Division of Nephrology, Kanazawa University Hospital, Kanazawa, Japan 920-8641
          [6 ]Division of Blood Purification, Kanazawa University Hospital, Kanazawa, Japan 920-8641
          [7 ]Department of Laboratory Medicine and Nephrology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan 920-8641
          [8 ]Department of Molecular Biology, Helen L. Dorris Institute for Neurological and Psychiatric Disorders, The Scripps Research Institute, La Jolla, CA 92037
          [9 ]Division of Nephrology, Department of Medicine, Center for Lung Biology and Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109
          [10 ]Biogen, Cambridge, MA 02139
          Author notes
          Address correspondence to: Norihiko Sakai, M.D., Ph.D., Division of Nephrology, Division of Blood Purification, Kanazawa University Hospital, Kanazawa, Japan 920-8641; norin0826@ 123456yahoo.co.jp ; Tel: 81-76-265-2233; Fax: 81-76-234-4250 or Andrew M. Tager, M.D., Fibrosis Research Center, Massachusetts General Hospital, 149 13 th Street, Room 8301, Charlestown, MA 02129; amtager@ 123456mgh.harvard.edu ; Tel: (617) 724-7368; Fax: (617) 726-5651
          Article
          PMC5313343 PMC5313343 5313343 nihpa825095
          10.1016/j.kint.2016.09.030
          5313343
          27927603
          3de8811f-b59b-4a02-b92b-7d2261dfbf2d
          History
          Categories
          Article

          Fibrosis,fibroblast,LPA1 ,CTGF
          Fibrosis, fibroblast, LPA1 , CTGF

          Comments

          Comment on this article